Pyruvate oxidation in neuromuscular diseases
Evidence of a genetic defect in two families with the clinical syndrome of Friedreich's ataxia*
Citation Manager Formats
Make Comment
See Comments

Abstract
To seek clues of metabolic derangements in neurornuscular diseases, the oxidations of pyruvate and succinate were studied in biopsied muscle. Pyruvate oxidation in 7 of 19 spinocerebellar degenerations (0.327± 0.040 prnoles × gm-1 noncollagenous protein content × hr-l) and 8 of 19 motor neuropathies (0.367± 0.029) was less than in controls with myopathic disease (1.096±0.91) or normal muscle (1.707± 0.181) (means± S.E.M.). The rates were independent of several physiologic variables, of the ratios of Type I::Type ll fibers in the specimens, and of the degree of neuropathy. Succinate was oxidized normally. Serially cultured fibroblasts from three patients from families with Friedreich's ataxia also oxidized pyruvate more slowly than did controls (0.11± 0.03 vs. 0.30± 0.02 cpm × mcg-1' protein × hr-1. These two families with ataxia appear to have a genetic defect that affects pyruvate oxidation in some unknown way.
- © 1974 by the American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.